Regardless, a T cell vaccine that elicits HIV-1-specific CD8+ T cells was expected to prevent HIV-1 infection because many studies have demonstrated that HIV-1-specific cytotoxic T lymphocytes (CTLs) have an important role in suppressing HIV-1 replication in those with acute or chronic HIV-1 infection.5 This evidence concerns the gene CD8A and HIV-1 infection.